Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 64726 - 64750 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Reserpine	Approved Withdrawn	CYP3A4	1576	upregulated	Reserpine results in increased expression of CYP3A4 mRNA	7q22.1	A20983
Reserpine	Approved Withdrawn	GCNT3	9245	upregulated	Reserpine results in increased expression of GCNT3 mRNA	15q22.2	A20662
Reserpine	Approved Withdrawn	IL10	3586	downregulated	Reserpine results in decreased expression of IL10 mRNA	1q32.1	A23841
Reserpine	Approved Withdrawn	SIAH1	6477	upregulated	Reserpine results in increased expression of SIAH1 mRNA	16q12.1	A23840
Reserpine	Approved Withdrawn	SQSTM1	8878	upregulated	Reserpine results in increased expression of SQSTM1 mRNA	5q35.3	A20662
Resorcinol	Approved Investigational	AKR1B10	57016	upregulated	resorcinol results in increased expression of AKR1B10 mRNA	7q33	A20662
Resorcinol	Approved Investigational	FBXO30	84085	upregulated	resorcinol results in increased expression of FBXO30 mRNA	6q24.3	A20662
Resorcinol	Approved Investigational	LIF	3976	upregulated	resorcinol results in increased expression of LIF mRNA	22q12.2	A20662
Resorcinol	Approved Investigational	PTGS2	5743	downregulated	resorcinol results in decreased expression of PTGS2 mRNA	1q31.1	A22791
Resorcinol	Approved Investigational	SLC7A11	23657	downregulated	resorcinol results in decreased expression of SLC7A11 mRNA	4q28.3	A20662
Resveratrol	Investigational	ABCA1	19	upregulated	resveratrol results in increased expression of ABCA1 mRNA	9q31.1	A23842 A23843
Resveratrol	Investigational	ABCB1	5243	downregulated	resveratrol results in decreased expression of ABCB1 mRNA	7q21.12	A23844 A22766
Resveratrol	Investigational	ABCB1	5243	upregulated	resveratrol results in increased expression of ABCB1 mRNA	7q21.12	A22792
Resveratrol	Investigational	ABCB1	5243	downregulated	[resveratrol results in increased susceptibility to Doxorubicin] which results in decreased expression of ABCB1 mRNA	7q21.12	A22423
Resveratrol	Investigational	ABCB9	23457	upregulated	resveratrol results in increased expression of ABCB9 mRNA	12q24.31	A23845
Resveratrol	Investigational	ABCC2	1244	downregulated	resveratrol results in decreased expression of ABCC2 mRNA	10q24.2	A22766
Resveratrol	Investigational	ABCC3	8714	upregulated	resveratrol results in increased expression of ABCC3 mRNA	17q21.33	A22792
Resveratrol	Investigational	ABCG1	9619	upregulated	resveratrol results in increased expression of ABCG1 mRNA	21q22.3	A23842
Resveratrol	Investigational	ABCG2	9429	downregulated	resveratrol results in decreased expression of ABCG2 mRNA	4q22.1	A23846
Resveratrol	Investigational	ABCG2	9429	downregulated	resveratrol results in decreased expression of ABCG2 mRNA alternative form	4q22.1	A23386
Resveratrol	Investigational	ABCG2	9429	upregulated	resveratrol results in increased expression of ABCG2 mRNA	4q22.1	A22624 A23386
Resveratrol	Investigational	ABHD15	116236	upregulated	resveratrol results in increased expression of ABHD15 mRNA	17q11.2	A22289
Resveratrol	Investigational	ABLIM1	3983	upregulated	resveratrol results in increased expression of ABLIM1 mRNA	10q25.3	A23847
Resveratrol	Investigational	ACADM	34	upregulated	resveratrol results in increased expression of ACADM mRNA	1p31.1	A23848
Resveratrol	Investigational	ACLY	47	upregulated	resveratrol results in increased expression of ACLY mRNA	17q21.2	A21627

Displaying entries 64726 - 64750 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability